A lack of opioid and dopamine uptake in the AD dorsal striatum followed profound GABA reuptake, indicated by a high Slc6a11 expression increase in AD vs. A20 (q < 0.00135; Table S3), implying that MSN GABAergic signaling stalls in AD species. The gene discussed is SLC6A11; the disease is Alzheimer disease.